Stereotaxis, Inc. (NYSEAMERICAN:STXS) Shares Sold by Legato Capital Management LLC

Legato Capital Management LLC lessened its position in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 23.7% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 360,291 shares of the company’s stock after selling 111,859 shares during the quarter. Legato Capital Management LLC’s holdings in Stereotaxis were worth $821,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of STXS. SG Americas Securities LLC bought a new position in Stereotaxis during the 3rd quarter worth approximately $39,000. Charles Schwab Investment Management Inc. lifted its holdings in Stereotaxis by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock worth $341,000 after buying an additional 15,491 shares during the last quarter. State Street Corp lifted its holdings in Stereotaxis by 5.7% during the 3rd quarter. State Street Corp now owns 680,612 shares of the company’s stock worth $1,388,000 after buying an additional 36,518 shares during the last quarter. Jane Street Group LLC lifted its holdings in Stereotaxis by 26.9% during the 3rd quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after buying an additional 6,313 shares during the last quarter. Finally, Barclays PLC lifted its holdings in Stereotaxis by 449.9% during the 3rd quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after buying an additional 83,412 shares during the last quarter. Institutional investors own 45.35% of the company’s stock.

Stereotaxis Stock Performance

Shares of NYSEAMERICAN STXS opened at $2.27 on Friday. The company has a market capitalization of $192.34 million, a P/E ratio of -8.11 and a beta of 1.54. Stereotaxis, Inc. has a 12-month low of $1.66 and a 12-month high of $3.29.

Stereotaxis (NYSEAMERICAN:STXS) last announced its quarterly earnings results on Monday, November 11th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.03). The company had revenue of $9.20 million during the quarter, compared to the consensus estimate of $6.80 million. Stereotaxis had a negative return on equity of 162.54% and a negative net margin of 85.79%. On average, research analysts forecast that Stereotaxis, Inc. will post -0.26 earnings per share for the current year.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.